Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CNO Financial Group, Inc. (NYSE: CNO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a life and health insurer and financial services provider focused on middle-income America, CNO uses its filings to present detailed information on its insurance products, capital position and operating performance.
Investors can review CNO’s current reports on Form 8-K, which the company uses to furnish quarterly earnings press releases, quarterly financial supplements and additional financial and operating data. These filings commonly include metrics such as net income, net operating income, income from insurance products across annuity, health and life lines, fee income, investment income not allocated to product lines, and measures like book value per share and operating return on equity.
Over time, CNO’s SEC filings also provide insight into capital management and structure, including common stock dividends, share repurchase activity, reinsurance transactions with its wholly owned Bermuda reinsurance company, and technology modernization initiatives such as the TechMod project. Filings may describe changes in business mix, such as the decision to exit the fee services side of the Worksite Division to focus on core insurance offerings.
On Stock Titan, AI-generated highlights help explain the key points in lengthy documents, so users can quickly understand what each filing means for CNO’s insurance operations, investment portfolio and shareholders. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while tools for viewing insider-related information, capital actions and recurring reporting patterns make it easier to analyze CNO’s regulatory history.
CNO Financial Group's Chief Human Resources Officer, Yvonne K. Franzese, sold 9,000 shares of common stock in three open-market transactions on February 17, 2026. The sales were made under a Rule 10b5-1 trading plan adopted on August 20, 2025.
The reported weighted average sale prices were $43.1807, $43.1744 and $43.1638 per share, with individual trades occurring within disclosed ranges between $42.94 and $43.79 per share. Franzese also reports indirect ownership of 78,279 common shares held through the Yvonne K. Franzese Revocable Trust.
CNO Financial Group Chief Executive Officer Gary C. Bhojwani reported open-market sales of company common stock under a pre-arranged Rule 10b5-1 trading plan adopted on August 21, 2025. These trades are designed to execute automatically according to preset instructions rather than day-to-day market timing decisions.
On February 18, 2026, he sold 43,021 shares at a weighted average price of $43.0511 per share, and on February 17, 2026, he sold 45,357 shares at a weighted average price of $43.1657 per share. After these transactions, he held 277,526 shares directly and 635,471 shares indirectly through the Gary C. Bhojwani Revocable Trust.
CNO reported a Form 144 filing indicating the planned sale of 33,800 common shares by the reporting party on 02/18/2026. The filing also lists prior sales by Matthew Zimpfer of 23,570 shares on 02/17/2026 and 30,970 shares on 02/12/2026, reported with their respective aggregate values.
CNO Financial Group reported Form 144 transactions showing insider sales. The filing lists sales by Gary Bhojwani of 45,357 shares for $1,957,866.65 on 02/17/2026, 31,430 shares for $1,319,641.98 on 01/02/2026, and 31,430 shares for $1,256,222.53 on 11/20/2025.
The form also identifies Performance Shares tied to 02/10/2026 under an "ISSUER" designation. The filing is a routine disclosure of proposed or completed sales under resale rules.
An insider of CNO, identified as Matthew Zimpfer, has filed a notice of intent to sell 23,570 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1,017,413.19. The shares are part of a class with 95,353,512 shares outstanding and are expected to be sold on or about 02/17/2026 on the NYSE.
The shares to be sold were acquired on 02/17/2026 via a stock option exercise from the issuer for cash. Zimpfer also sold 30,970 common shares in a prior transaction on 02/12/2026 for gross proceeds of 1,329,582.36. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about the issuer’s operations.
CNO Financial insider Gary Bhojwani filed a notice to sell 45,357 shares of CNO common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney on the NYSE around 02/17/2026, has an aggregate market value of 1957866.65.
The shares to be sold are performance shares of common stock acquired from the issuer on 02/10/2026. In the past three months, Bhojwanii also sold 31,430 common shares on 01/02/2026 for gross proceeds of 1319641.98 and 31,430 shares on 11/20/2025 for 1256222.53.
CNO Financial Group insider Yvonne K. Franzese has filed a Form 144 indicating an intention to sell 9,000 shares of CNO common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $388,556.70 and an approximate sale date of February 17, 2026 on the NYSE.
The notice shows these 9,000 shares were acquired as performance shares from the issuer on February 10, 2026. It also discloses a prior sale of 3,000 common shares on November 24, 2025 for gross proceeds of $123,000. Shares outstanding were 95,353,512 as of the filing, which is a baseline figure, not the amount being sold.
By signing the notice, the seller represents that they do not know of any material adverse, nonpublic information about CNO’s operations, and acknowledges the additional representation required if relying on a Rule 10b5-1 trading plan.
CNO Financial Group executive Scott L. Goldberg reported equity award activity. On February 10, 2026, he acquired 26,071 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023 operating return on equity, 2023 operating earnings per share, and three-year relative total shareholder return for 2023-2025.
On the same date, 8,185 common shares were surrendered to CNO to cover required tax withholding on the vested performance share units, leaving 198,724 common shares beneficially owned directly. Goldberg also received 15,800 restricted stock units at $0 per unit, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, bringing his directly held restricted stock units to 214,524.
CNO Financial Group’s President, Consumer Division reported an amended insider transaction. On February 10, 2023, the officer exercised employee stock options for 17,095 shares of common stock at $16.42 per share, then sold 17,095 shares at a weighted average price of $25.3397 under a Rule 10b5-1 trading plan adopted on November 11, 2022. Following these transactions, the officer directly beneficially owned 137,305 shares of CNO common stock. The amendment also corrects the presentation of the option exercise and the post-transaction share balance, and notes the options had vested on February 25, 2018 and were scheduled to expire on February 25, 2025.
CNO Financial Group Chief Executive Officer and director Gary C. Bhojwani reported equity compensation activity. On February 10, 2026, he acquired 152,542 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 performance metrics.
On the same date, 64,164 shares of common stock were disposed of at $43.05 per share to satisfy required tax withholding on the vested performance share units. He also received a grant of 81,600 restricted stock units at no cost, which convert one-for-one into common stock and vest in three equal annual installments beginning March 25, 2027, subject to continued employment.